31![Abstract #: 281 M-ONC 402-a non anticoagulant low molecular weight heparin inhibits tumor metastasis He Zhou, Nancy Dussault, Edward Cochran, Rain Kwan, Juliane Karlgren, Marishka Barnes, Sucharita Roy, Radouane Zouaoui Abstract #: 281 M-ONC 402-a non anticoagulant low molecular weight heparin inhibits tumor metastasis He Zhou, Nancy Dussault, Edward Cochran, Rain Kwan, Juliane Karlgren, Marishka Barnes, Sucharita Roy, Radouane Zouaoui](https://www.pdfsearch.io/img/61d0e27f623c0938ce5c1493251c1b12.jpg) | Add to Reading ListSource URL: www.momentapharma.comLanguage: English - Date: 2012-06-27 14:59:09
|
---|
32![Protecting yourself Staying informed The anticoagulant Xarelto® Protecting yourself Staying informed The anticoagulant Xarelto®](https://www.pdfsearch.io/img/7234381d21865e8a39ff3c4a428e9d42.jpg) | Add to Reading ListSource URL: healthcare.bayer.comLanguage: English - Date: 2014-04-22 04:22:01
|
---|
33![Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou](https://www.pdfsearch.io/img/80cb29c3027f798a769860f2a6e8e3c4.jpg) | Add to Reading ListSource URL: www.momentapharma.comLanguage: English - Date: 2012-06-27 14:59:07
|
---|
34![Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica](https://www.pdfsearch.io/img/685ef76f3b264a012cda37f7969441aa.jpg) | Add to Reading ListSource URL: www.momentapharma.comLanguage: English - Date: 2012-06-27 15:00:31
|
---|
35![Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou](https://www.pdfsearch.io/img/4d8966120f61121eaf4b44a78d9932a9.jpg) | Add to Reading ListSource URL: www.momentapharma.comLanguage: English - Date: 2012-06-27 15:02:02
|
---|
36![Abstract # 5005 M-ONC 402, a novel non-anticoagulant heparin, inhibits P-Selectin function and metastatic seeding of tumor cells in mice Chia Lin Chu, Jay Duffner, Nancy Dussault, Alison Long, Sucharita Roy, Radouane Z Abstract # 5005 M-ONC 402, a novel non-anticoagulant heparin, inhibits P-Selectin function and metastatic seeding of tumor cells in mice Chia Lin Chu, Jay Duffner, Nancy Dussault, Alison Long, Sucharita Roy, Radouane Z](https://www.pdfsearch.io/img/00fc5d8273ece4e204214ce634d69fa1.jpg) | Add to Reading ListSource URL: www.momentapharma.comLanguage: English - Date: 2012-06-27 15:01:56
|
---|
37![HAZARD NOTICE By arrangement with the Scottish Government Health Directorates UNIPATH SMARTCHECK INR BLOOD COAGULATION TEST SYSTEM: PRODUCT RECALL HAZARD NOTICE By arrangement with the Scottish Government Health Directorates UNIPATH SMARTCHECK INR BLOOD COAGULATION TEST SYSTEM: PRODUCT RECALL](https://www.pdfsearch.io/img/584b1896d1eff05f74b4ec492ff6ea49.jpg) | Add to Reading ListSource URL: www.hfs.scot.nhs.ukLanguage: English |
---|
38![Remote Monitoring // CASE STUDY Optimizing Anticoagulant Therapy Management: Roche’s Bold Connected Solution We believe the addition of mobile technology and cloud-based connectivity is a natural evolution for point-o Remote Monitoring // CASE STUDY Optimizing Anticoagulant Therapy Management: Roche’s Bold Connected Solution We believe the addition of mobile technology and cloud-based connectivity is a natural evolution for point-o](https://www.pdfsearch.io/img/ca09b51acb768c41325f47bab2bbe021.jpg) | Add to Reading ListSource URL: www.qualcommlife.comLanguage: English - Date: 2015-04-11 23:13:21
|
---|
39![Pharmaceutical Management Agency Annual Review 2011
Highlights Pharmaceutical Management Agency Annual Review 2011
Highlights](https://www.pdfsearch.io/img/0dac2e95aaef858342cbbcbef844567f.jpg) | Add to Reading ListSource URL: www.pharmac.govt.nzLanguage: English - Date: 2012-02-29 07:00:03
|
---|
40![NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Atrial Fibrillation NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Atrial Fibrillation](https://www.pdfsearch.io/img/56d0d63dab34e6efbf6ee86707b64926.jpg) | Add to Reading ListSource URL: www.nice.org.ukLanguage: English - Date: 2014-07-30 06:27:48
|
---|